AGA
Clinical trials for AGA explained in plain language.
Never miss a new study
Get alerted when new AGA trials appear
Sign up with your email to follow new studies for AGA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to fight genetic hair loss
Disease control OngoingThis study is testing an investigational oral tablet called VDPHL01 to see if it is safe and effective for treating genetic hair loss (pattern baldness) in men and women. About 70 participants will take the pill daily for one year while researchers track changes in hair count and…
Matched conditions: AGA
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:26 UTC
-
New pill aims to fight hair loss in men
Disease control OngoingThis study is testing a new oral pill called VDPHL01 to see if it is safe and effective for treating male pattern baldness. It will involve about 480 men aged 18-65 with mild to moderate hair loss over a 13-month period. Researchers will compare the pill to a placebo to measure c…
Matched conditions: AGA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Pill for baldness? new drug trial seeks to regrow hair
Disease control OngoingThis study is testing whether an oral pill called VDPHL01 can help regrow hair in men with male pattern baldness. About 480 men will take either the pill or a placebo for 6 months, followed by an extension where everyone gets the active drug. The main goals are to see if the pill…
Matched conditions: AGA
Phase: PHASE2, PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC